HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control.
Fiche publication
Date publication
août 2022
Journal
Cardiovascular diabetology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DUVILLARD Laurence, Pr VERGES Bruno, Mr MONIER Serge
Tous les auteurs :
Denimal D, Monier S, Simoneau I, Duvillard L, Vergès B, Bouillet B
Lien Pubmed
Résumé
Reduced cholesterol efflux capacity (CEC) of HDLs is likely to increase cardiovascular risk in type 1 diabetes (T1D). We aimed to assess whether improvement of glycemic control in T1D patients is associated with changes in CEC in relation with changes in carbamylation of HDLs.
Mots clés
Carbamylation, Cholesterol efflux, HDL, Type 1 diabetes
Référence
Cardiovasc Diabetol. 2022 08 12;21(1):154